Status:
UNKNOWN
Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor
Lead Sponsor:
Copenhagen University Hospital at Herlev
Conditions:
Liver Metastasis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to see if treatment with intrahepatic chemotherapy is a good options in patients with liver metastases. If the patients have colorectal cancer and never had got chemothera...
Detailed Description
Two regiment are used: N.B. The two regiments will be reported separately 1. Mitomycin + Gemcitabine intrahepatic together with Capecitabine. This treatment can be offered patients with solid tumors ...
Eligibility Criteria
Inclusion
- liver metastasis
- solid tumor
Exclusion
- poor performance
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01511146
Start Date
July 1 2011
End Date
July 1 2016
Last Update
January 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev Hospital
Herlev, Denmark, 2730